Literature DB >> 6976960

SQ 26,776: in-vitro antibacterial activity and susceptibility to beta-lactamases.

I Phillips, A King, K Shannon, C Warren.   

Abstract

Mesh：

Substances：

Year:  1981        PMID： 6976960     DOI： 10.1093/jac/8.suppl_e.103

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  11 in total

1.  Antibacterial activity of Ro 17-2301 and other antimicrobial agents against cefotaxime-resistant aerobic gram-negative bacilli.

Authors:  C A Benson; F E Walton; G M Trenholme
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

2.  Enzymatic inactivation of aztreonam by faecal enzyme preparations from healthy volunteers.

Authors:  G W Welling; G Groen; S Welling-Wester; H G de Vries-Hospers; D van der Waaij
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

3.  Comparative activities of aztreonam and cefotaxime against Escherichia coli and Bacteroides spp. in pure and mixed cultures.

Authors:  F Soriano; M C Ponte
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

4.  Evaluation of aztreonam in the treatment of severe bacterial infections.

Authors:  J Romero-Vivas; M Rodríguez-Créixems; E Bouza; T Hellín; A Guerrero; J Martínez-Beltrán; M García de la Torre
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

Review 5.  Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  R N Brogden; R C Heel
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

6.  Evaluation of aztreonam in experimental bacterial meningitis and cerebritis.

Authors:  W M Scheld; J P Brodeur; J C Gratz; P Foresman; G Rodeheaver
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

7.  Enterococcal superinfection and colonization with aztreonam therapy.

Authors:  P H Chandrasekar; B R Smith; J L LeFrock; B Carr
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

8.  Aztreonam treatment of gram-negative septicemia.

Authors:  D Pierard; J Boelaert; H W Van Landuyt; A Naessens; L Huyghens; S Lauwers
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

9.  Pharmacokinetics of aztreonam in patients with chronic renal failure.

Authors:  J P Fillastre; A Leroy; C Baudoin; G Humbert; E A Swabb; C Vertucci; M Godin
Journal:  Clin Pharmacokinet       Date:  1985 Jan-Feb       Impact factor: 6.447

10.  In vitro activity of azthreonam, a monobactam antibiotic.

Authors:  N V Jacobus; M C Ferreira; M Barza
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.